Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oral gold in arthritis.

C S Conner

    Drug Intelligence & Clinical Pharmacy
    |October 1, 1984
    PubMed
    Summary

    Auranofin, an oral gold compound, shows promise for rheumatoid arthritis treatment. While potentially less effective than injections, it offers reduced toxicity and may slow disease progression, warranting further investigation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Withered Yang: a review of traditional Chinese medical treatment of male infertility and erectile dysfunction.

    Journal of andrology·2001
    Same author

    Conflicting data in the literature: a true dilemma.

    Drug intelligence & clinical pharmacy·1986
    Same author

    beta-Lactamase inhibitors.

    Drug intelligence & clinical pharmacy·1985
    Same author

    Transdermal nitroglycerin: a reevaluation.

    Drug intelligence & clinical pharmacy·1984
    Same author

    Atracurium and vecuronium: two unique neuromuscular blocking agents.

    Drug intelligence & clinical pharmacy·1984
    Same author

    Alzheimer's disease: clinical features, pathogenesis, and treatment.

    Drug intelligence & clinical pharmacy·1984

    Area of Science:

    • Rheumatology
    • Pharmacology
    • Drug Development

    Background:

    • Rheumatoid arthritis treatments with disease-modifying or healing effects are limited.
    • Parenteral gold and cyclophosphamide are established agents but associated with significant toxicity.
    • Auranofin (Ridaura) is an emerging oral gold compound for rheumatoid arthritis management.

    Purpose of the Study:

    • To evaluate the efficacy and safety of auranofin in rheumatoid arthritis patients.
    • To compare auranofin's therapeutic profile with parenteral gold treatments.
    • To assess auranofin's potential to slow radiologic progression in rheumatoid arthritis.

    Main Methods:

    • Clinical studies investigating auranofin's effects in rheumatoid arthritis.
    • Comparative analysis of auranofin versus parenteral gold.
    • Assessment of toxicity and side effect profiles, including diarrhea.
    • Radiologic evaluation to determine impact on disease progression.

    Main Results:

    • Auranofin demonstrates a potentially lower efficacy compared to parenteral gold.
    • Auranofin exhibits significantly reduced toxicity, with diarrhea as the primary side effect.
    • Evidence suggests auranofin may slow the radiologic progression of rheumatoid arthritis.

    Conclusions:

    • Auranofin presents a potentially safer alternative to parenteral gold for rheumatoid arthritis.
    • Further research is needed to confirm auranofin's disease-modifying or healing capabilities.
    • Auranofin could emerge as a first-line therapy for rheumatoid arthritis if healing effects are substantiated.

    Related Experiment Videos